3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
7
INDUSTRY
5
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Genitourinary
1
Conditions
Lymphoma, B-Cell
1
Interventions
Cyclophosphamide
12
Rituximab
9
fludarabine
6
Prednisone
5
Vinorelbine
4
Vincristine
4
Epirubicin
4
zanubrutinib
3
Nivolumab
3
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
3
Gemcitabine
3
Drug Therapy
3
pegylated granulocyte colony-stimulating factor
2
fludarabine phosphate
2
Thiotepa
2
Metformin
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Doxorubicin
2
Cytarabine
2
Bortezomib
2
treosulfan
1
plerixafor
1
pegfilgrastim
1
parsaclisib
1
obinutuzumab
1
nilotinib
1
liposomal doxorubicin
1
ivarmacitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
avelumab
×
Lymphoid
×
Clear all
NCT03244176
2024-07-30
AvR-CHOP
Austin Health
Phase EARLY_PHASE1
Active not recruiting
28 enrolled